Kliničke smjernice za dijagnosticiranje, liječenje i praćenje bolesnika s rakom jednjaka i gastroezofagealnog prijelaza (CROSBI ID 300620)
Prilog u časopisu | stručni rad | domaća recenzija
Podaci o odgovornosti
Bišof Vesna, Juretić Antonio, Stančić-Rokotov Dinko, Rustemović Nadan, Miletić Damir, Boban Marijo, Omrčen Tomislav, Jakić Razumović Jasminka, Pavlović Ira, Fröbe Ana, Čonkaš Mislav, Rakušić Zoran, Gugić Damir
hrvatski
Kliničke smjernice za dijagnosticiranje, liječenje i praćenje bolesnika s rakom jednjaka i gastroezofagealnog prijelaza
Esophageal and esophagogastric junction cancers comprise histologically and biologically different malignant tumors in which the progress in the understanding of the disease has not been followed by the improvement in the survival. Diagnosis is set by tumor biopsy during endoscopy. Multimodal approaches containing surgery, radiotherapy and chemotherapy are frequently applied in the treatment of locoregionally advanced disease. However, the optimal sequence of the treatment options is still the issue of numerous clinical trials and meta-analyzes. Metastatic disease is treated with palliative chemotherapy and best supportive care. Treatment decisions should be individualized according to patients’ characteristics and made after multidisciplinary team discussion. The following text presents the clinical guidelines in order to standardize the diagnostic procedures, treatment and monitoring of patients with esophageal and esophagogastric junction cancers in the Republic of Croatia.
Kliničke smjernice, rak jednjaka, rak gastroezofagealnog prijelaza
nije evidentirano
engleski
Clinical recommendations for diagnosis, treatment and monitoring of patients with esophageal and esophagogastric junction cancers
nije evidentirano
Clinical guidelines, oesophageal cancer, gastroesophageal junction
nije evidentirano
Podaci o izdanju
138 (9-10)
2016.
233-239
objavljeno
0024-3477
1849-2177